Still feeling hungry on semaglutide — and wondering why?

You're a few weeks in, the pen is in the fridge, and you're still hungry, here's what that usually means

Picture this: you've been on semaglutide for three or four weeks, you're on the starting dose, and you expected the appetite suppression you've read about. Instead, mealtimes feel much the same as before. This is one of the most common experiences people bring to their prescribers, and the explanation is straightforward.

Semaglutide works partly by acting on GLP-1 receptors in the brain's appetite-regulation centres and partly by slowing how quickly food leaves the stomach. Both effects tend to intensify as the dose increases through the titration ladder. The 0.25mg starting dose exists primarily to let your body adjust and minimise gastrointestinal side effects, it isn't the dose at which most people notice strong appetite suppression. The NHS medicines page for semaglutide describes this phased approach clearly: appetite effects generally strengthen as treatment progresses through 0.5mg, 1.0mg, 1.7mg and up to the 2.4mg (or higher) maintenance dose.

If you've recently moved up a dose step, give it a few weeks. Most of the pharmacological effect at a new dose establishes itself over two to three weeks. Expecting maximum suppression on day one of a new pen is like expecting a full night's sleep from the first pill of a new supplement, the system needs time to settle.

One pattern worth knowing: hunger often returns more sharply towards the end of the dosing week, Thursday or Friday if you inject on Monday. That end-of-week dip is a recognised feature of once-weekly GLP-1 medicines and is tied to plasma levels naturally declining before the next dose. It isn't a malfunction; it's pharmacokinetics.

What you eat changes how hungry semaglutide leaves you feeling

Even with semaglutide slowing gastric emptying, meal composition still shapes how satisfied you feel afterwards, and for how long. A breakfast of white toast and jam will leave most people on GLP-1 treatment hungry well before lunch. A breakfast built around eggs, Greek yoghurt, or oats with added protein takes longer to move through the stomach and keeps satiety signals running longer.

The practical principles here are well-established. Protein is the most satiating macronutrient per calorie. Fibre slows digestion and adds physical bulk. Fat, in moderate amounts, also slows gastric emptying, which semaglutide is already doing, which is why some people find fatty meals sit uncomfortably. Finding a balance that keeps you full without triggering nausea is personal work, ideally done with your prescriber or a dietitian.

Hydration matters too. Thirst is frequently mistaken for hunger, and semaglutide treatment can sometimes reduce the natural cues that remind people to drink. A glass of water before a meal isn't a folk remedy, it's a practical tool that several people on GLP-1 treatment find reduces the urge to eat more than they intended.

For a more detailed look at which foods tend to work well alongside this treatment, our guide on what to eat on Wegovy covers the practical food choices that complement semaglutide's mechanism. And if you're curious how the overall picture of hunger and appetite shifts through treatment, this page on eating on semaglutide covers what normal looks like at different stages.

When persistent hunger is worth a conversation with your prescriber

Not all ongoing hunger is just the titration phase working through its natural timeline. There are situations where it's genuinely worth flagging to the clinician managing your treatment.

If you've been on your current dose for six or more weeks and hunger feels unchanged from before you started, that's useful information. It may mean the dose hasn't yet reached the therapeutic range that produces meaningful appetite reduction for you, individual responses vary, and some people need a higher maintenance dose before the effect is noticeable. The NICE appraisal of semaglutide for weight management (TA875) notes that if significant weight loss hasn't occurred after six months at the maintenance dose, continuing treatment should be reviewed, which underlines why clinical oversight matters throughout, not just at the start.

Stress, poor sleep, and certain medications can all blunt the appetite-suppression effect of GLP-1 medicines independently of the dose. A prescriber who knows your full picture can help identify whether something else is contributing.

Separately, it's worth knowing that semaglutide is available as an injection (Wegovy) and, since June 2026, as a once-daily tablet. The two formulations have different dosing schedules and absorption profiles, which can affect how consistent appetite suppression feels across the day or week. If you're comparing experiences between the two, our Wegovy overview sets out what distinguishes them.

If cost is a factor in whether you're taking treatment consistently (perhaps skipping a pen one month) that's a real pattern, and it directly affects outcomes. Our Wegovy cost comparison page sets out what private treatment typically involves and what a transparent price should include. Missing doses because of cost pressure is worth raising openly with your prescriber too, not just quietly managing around it. Orders placed before noon on a weekday go out the same day from our pharmacy, useful to know if you're cutting it fine before a bank holiday or a trip away.

If you'd like a prescriber to look at your specific situation, speak to our prescribers, they review consultations the same day, and any conversation about hunger, dose or diet is a reasonable one to have.